ArticleFrontiers in immunology2025

Intratumoral sustained release of resiquimod with ablative fractional laser induces efficacy in a cutaneous squamous cell carcinoma mouse model.

Martin Wiinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.